Patents by Inventor Lalo Magni

Lalo Magni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9827371
    Abstract: A method (400) controls the delivery of insulin in a diabetic patient (P) based on data (d) representative of at least a fraction of a meal (m(k+i)) that the patient (P) will consume. The method provides from a block (R) representative of conventional therapy or open loop rule that the patient (P) is subject to, based on the data (d) representative of at least a fraction of the meal (m(k+i)), a reference insulin value (u0). The method is also based on data representative of the difference between input data (?), a reference glycemic level, and feedback data (yCGM) representative of the glycemic level detected in the patient (P). A control module (301; 401) provides a value of insulin (i) to be delivered to the patient (P) based on the various representative data.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: November 28, 2017
    Assignees: DIPARTIMENTO DI INGEGNERIA CIVILE E ARCHITETTURA DELL‘UNIVERSITA’ DEGLI STUDI DI PAVIA, UNIVERSITA' DEGLI STUDI DI PADOVA
    Inventors: Paola Soru, Lalo Magni, Chiara Toffanin, Giuseppe De Nicolao, Chiara Dalla Man, Claudio Cobelli
  • Publication number: 20150174322
    Abstract: A method (400) controls the delivery of insulin in a diabetic patient (P) based on data (d) representative of at least a fraction of a meal (m(k+i)) that the patient (P) will consume. The method provides from a block (R) representative of conventional therapy or open loop rule that the patient (P) is subject to, based on the data (d) representative of at least a fraction of the meal (m(k+i)), a reference insulin value (u0). The method is also based on data representative of the difference between input data (?), a reference glycemic level, and feedback data (yCGM) representative of the glycemic level detected in the patient (P). A control module (301; 401) provides a value of insulin (i) to be delivered to the patient (P) based on the various representative data.
    Type: Application
    Filed: March 23, 2012
    Publication date: June 25, 2015
    Applicants: UNIVERSITA' DEGLI STUDI DI PADOVA, DIPARTIMENTO DI INGEGNERIA CIVILE E ARCHITETTURA DELL'UNIVERSITA' DEGLI STUDI DI PAV
    Inventors: Paola Soru, Lalo Magni, Chiara Toffanin, Giuseppe De Nicolao, Chiara Dalla Man, Claudio Cobelli
  • Publication number: 20120245556
    Abstract: A method, system and computer program product for correcting a nominal treatment strategy of a subject with diabetes. The method, system and computer program product may be configured for providing input whereby the input may include: open-loop therapy settings for the subject, data about glycemic state of the subject; and (optionally) data about meals and/or exercise of the subject. The method, system and computer program product may be configured for providing output, whereby the out-put may include an adjustment (correction) to the open-loop therapy settings for the subject for insulin delivery to the subject.
    Type: Application
    Filed: August 31, 2010
    Publication date: September 27, 2012
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Boris P. Kovatchev, Giuseppe DeNicolao, Lalo Magni, Chiara Dalla Man, Claudio Cobelli
  • Publication number: 20100262117
    Abstract: A system and method for providing optimal insulin injections to a subject, using a controller, a continuous glucose monitor, and an insulin delivery unit is disclosed. The controller possesses a discrete-time, linear model predictive control law, means for sending information to the insulin delivery unit, and means for receiving information from the CGM. The control law implemented is derived from a discrete-time model of glucose insulin dynamics and an aggressiveness parameter. The result is that using only glucose measurements obtained from sensor readings and, prior values of external insulin infusion and meal and exercise announcement the optimal insulin injection necessary to safely regulate blood glucose can be calculated.
    Type: Application
    Filed: October 31, 2008
    Publication date: October 14, 2010
    Applicant: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
    Inventors: Lalo Magni, Giuseppe De Nicolao, Davide Martino Raimondo, Claudio Cobelli, Chiara Dalla Man